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genotyping M. bovis strains isolated 
from farm animals to help elucidate 
the source of infection and transmis-
sion of M. bovis in Taiwan.
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To the Editor: Brucellosis is a 
zoonotic disease that remains endemic 
to many parts of the world. There are 
6 classic Brucella species described 
with different preferred hosts. Human 
disease is most commonly associated 
with consumption of unpasteurized 
dairy products or with occupational 
exposure for veterinarians, agricultur-
al workers, laboratory workers, meat 
industry workers, and hunters.
In recent years, it has become 
clear that novel members of the genus, 
yet to be formally named, are associ-
ated with a variety of marine mammal 
species, particularly dolphins, por-
poises, and seals (1). To date there are 
3 reports in the literature of naturally 
acquired infection of humans with 
Brucella species originating from ma-
rine mammals (2,3) One other case, 
representing infection of a laboratory 
worker, has also been reported (4). 
Two of the naturally acquired cases 
were reported in Peru (2). One per-
son had consumed raw shellfi sh and 
swam in the Pacifi c Ocean but did not 
report any direct contact with marine 
mammals; the second person reported 
infrequent visits to the coast and no 
contact with marine mammals but had 
consumed raw shellfi sh. An additional 
naturally acquired case was recently 
reported from New Zealand, where 
extensive molecular testing character-
ized the strain involved as a marine 
mammal type (3). This patient again 
reported no exposure to marine mam-
mals but did report that he fi shed regu-
larly, had contact with uncooked fi sh 
bait, and consumed raw snapper. The 
cases in Peru were notable for severe, 
atypical symptoms; both patients had 
symptoms of neurobrucellosis. The 
New Zealand case was associated with 
spinal osteomyelitis (3). In contrast, 
the laboratory-acquired infection was 
mild and uncomplicated (4).
We have characterized these iso-
lates by a variety of molecular ap-
proaches in conjunction with ongoing 
studies, which examine genetic diver-
sity within Brucella species isolated 
from marine mammals. Multilocus se-
quence analysis (5) showed that all 3 
isolates from naturally acquired human 
infection with Brucella species from 
marine mammals shared an identical 
genotype (ST27). In previous charac-
terization of 56 Brucella isolates from 
marine mammals, ST27 was found 
only once. Strain F5/99, originally 
isolated from an aborted bottlenose 
dolphin fetus off the western coast of 
the United States (6), shares this geno-
type. Use of an alternative typing ap-
proach, based on restriction fragment 
length polymorphism analysis of outer 
membrane protein–encoding genes 
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(7), gave identical fi ndings. Again, 
all 3 isolates derived from naturally 
acquired human infection represent 
an identical genotype. This genotype 
is shared only by strain F5/99 among 
a collection of 120 Brucella isolates 
from marine mammals characterized 
by this method. Finally, isolates were 
characterized by a variable number 
of tandem repeats–based typing ap-
proach (8). When comparing profi les 
at 6 loci with a relatively slow evolu-
tionary speed, previously shown to be 
useful for dividing Brucella isolates 
into species groups (8), we determined 
that F5/99 and the 3 naturally acquired 
human isolates share a unique profi le 
not seen in any of >1,400 isolates of 
marine or terrestrial Brucella spe-
cies examined to date. In contrast, the 
strain associated with laboratory-ac-
quired infection (4) was not a member 
of ST27 but belonged to ST23, a geno-
type that is predominantly associated 
with porpoises (9).
It is clear from these fi ndings that 
the 3 cases of naturally acquired infec-
tion with Brucella species originating 
from marine mammals reported to date 
were caused by closely related organ-
isms. The particular genotype con-
cerned, ST27, is rare in our collection, 
having been noted only once in marine 
mammals. However, this may refl ect 
the fact that most isolates examined to 
date originated from northern Europe; 
only 5 isolates in our collection origi-
nated from Pacifi c waters. It is possible 
that isolates of this genotype are pre-
dominantly or exclusively associated 
with regions other than those exten-
sively sampled to date. Indeed, exami-
nation of the literature provides further 
evidence for the presence of this geno-
type in marine mammals in the Pacifi c. 
BLAST (www.ncbi.nlm.nih.gov/blast) 
comparison of outer membrane protein 
sequences from a minke whale isolate 
originating in the North Pacifi c (10) 
showed a close match with the equiva-
lent sequence from F5/99.
Although numbers are currently 
small, the isolation of an identical 
genotype from all 3 cases of natural-
ly acquired human infection derived 
from marine mammal Brucella spe-
cies raises the possibility of increased 
zoonotic potential associated with this 
genotype. Furthermore, where diagno-
sis is based on serologic testing alone, 
it is possible that human infection with 
marine mammal Brucella species may 
go unnoticed. Members of ST27 may 
be more pathogenic to man, per se. 
Alternatively, they may be associated 
with natural hosts or circulate through 
intermediaries that make contact with 
humans more likely. Notably, none of 
the 3 patients reported direct contact 
with marine mammals, though all had 
consumed raw seafood. These fi nd-
ings clearly suggest that more exten-
sive studies of the presence and dis-
tribution of marine mammal Brucella 
genotypes, particularly ST27, in wa-
ters other than those of northern Eu-
rope would be valuable for clarifying 
the natural habitat of ST27. Further-
more, relevant authorities should be 
aware of the potential for zoonotic 
disease caused by this Brucella geno-
type particularly, but not exclusively, 
where occupation or lifestyle may 
make exposure more likely.
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